Skip to main content

Table 2 Characteristics of patients with pressure ulcers after propensity score matching

From: Active topical therapy by “Furuta method” for effective pressure ulcer treatment: a retrospective study

  d2 D3 D4, 5 DU
  Compliance group (n = 101) Non-compliance group (n = 101) Absolute standardized difference, % Compliance group (n = 65) Non-compliance group (n = 65) Absolute standardized difference, % Compliance group (n = 38) Non-compliance group (n = 38) Absolute standardized difference, % Compliance group (n = 38) Non-compliance group (n = 38) Absolute standardized difference, %
Age (years) 81.9 ± 8.5 82.4 ± 8.2 5.9 82.4 ± 8.6 81.8 ± 10.8 6.1 80.8 ± 12.0 80.3 ± 11.9 4.2 78.2 ± 11.0 77.6 ± 14.3 4.7
Sex (male) (%) 53.4 55.4 4.4 52.3 49.2 4.4 31.6 39.5 9.8 47.4 47.4 0
Hemoglobin (g/dL) 10.7 ± 2.1 10.9 ± 2.0 9.8 10.3 ± 1.9 10.4 ± 1.7 5.5 10.2 ± 2.1 10.3 ± 1.5 5.5 10.1 ± 2.0 10.3 ± 1.8 5.3
Albumin (g/dL) 2.9 ± 0.6 2.9 ± 0.6 0 2.6 ± 0.5 2.6 ± 0.6 0 2.6 ± 0.7 2.6 ± 0.7 0 2.6 ± 0.6 2.6 ± 0.6 9.8
DESIGN-R score at baseline 8.6 ± 4.4 8.2 ± 4.5 8.9 14.7 ± 7.7 15.1 ± 6.5 5.6 25.9 ± 11.4 25.0 ± 9.8 8.5 21.5 ± 8.4 22.1 ± 7.0 7.8
Observational period (day) 23.9 ± 21.1 22.6 ± 21.5 6.1 46.6 ± 53.4 42.1 ± 38.5 9.6 66.3 ± 47.2 63.3 ± 45.8 7.1 49.0 ± 61.5 45.1 ± 42.3 7.4
Locations             
Sacrum 39 47   23 26 - 20 22 - 11 15 -
Coccyx 14 7 - 5 4 - 1 3 - 2 2 -
Greater trochanter 7 8 - 7 4 - 2 1 - 8 4 -
Heel 9 12 - 11 7 - 3 1 - 7 10 -
Ilium 3 6 - 3 5 - 1 2 - 2 2 -
Others 29 21 - 16 19 - 11 9 - 8 5 -